Long-acting rhGH (New Formulations)
Pediatric Growth Hormone Deficiency
DevelopmentActive
Key Facts
Indication
Pediatric Growth Hormone Deficiency
Phase
Development
Status
Active
Company
About Changchun High-Tech Industry
Changchun High-Tech Industry's mission is to be a leading innovator in China's biopharmaceutical sector, focusing on vaccines and recombinant protein therapeutics. The company has achieved significant commercial success with blockbuster products like its recombinant human growth hormone (rhGH) and a diversified vaccine portfolio, establishing itself as a market leader in its core therapeutic areas. Its strategy is built on deep vertical integration, continuous portfolio expansion through R&D and strategic partnerships, and capitalizing on supportive national healthcare policies to drive long-term growth.
View full company profileTherapeutic Areas
Other Pediatric Growth Hormone Deficiency Drugs
| Drug | Company | Phase |
|---|---|---|
| NGENLA™ (somatrogon) | Opko Health | Approved |
| TransCon hGH (lonapegsomatropin) | Ascendis Pharma | Approved |